Construction of Tumor Organoids and Their Application to Cancer Research and Therapy

Overview

Journal Theranostics

Date 2024 Jan 22

PMID 38250041

Authors

Jiajing Lv

Xuan Du

Miaomiao Wang

Jiacan Su

Yan Wei

Can Xu

Affiliations

Soon will be listed here.

Abstract

Cancer remains a severe public health burden worldwide. One of the challenges hampering effective cancer therapy is that the existing cancer models hardly recapitulate the tumor microenvironment of human patients. Over the past decade, tumor organoids have emerged as an 3D tumor model to mimic the pathophysiological characteristics of parental tumors. Various techniques have been developed to construct tumor organoids, such as matrix-based methods, hanging drop, spinner or rotating flask, nonadhesive surface, organ-on-a-chip, 3D bioprinting, and genetic engineering. This review elaborated on cell components and fabrication methods for establishing tumor organoid models. Furthermore, we discussed the application of tumor organoids to cancer modeling, basic cancer research, and anticancer therapy. Finally, we discussed current limitations and future directions in employing tumor organoids for more extensive applications.

Citing Articles

Application of tumor organoids simulating the tumor microenvironment in basic and clinical research of tumor immunotherapy.

Li Y, Liao W, Sun L Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(8):1316-1326.

PMID: 39788520 PMC: 11628225. DOI: 10.11817/j.issn.1672-7347.2024.240187.

Construction methods and latest applications of kidney cancer organoids.

Li Z, You Y, Feng B, Chen J, Gao H, Li F Oncol Rev. 2024; 18:1434981.

PMID: 39600908 PMC: 11588466. DOI: 10.3389/or.2024.1434981.

Applications and perspectives of tumor organoids in radiobiology (Review).

Yu J, Wang K, Tang Y, Zheng D Oncol Rep. 2024; 52(2).

PMID: 38904192 PMC: 11223011. DOI: 10.3892/or.2024.8759.

Nanostructured Biomaterials in 3D Tumor Tissue Engineering Scaffolds: Regenerative Medicine and Immunotherapies.

Angelopoulou A Int J Mol Sci. 2024; 25(10).

PMID: 38791452 PMC: 11121067. DOI: 10.3390/ijms25105414.

References

Wu Y, Zhao Z, Guan Y, Zhang Y . Galactosylated reversible hydrogels as scaffold for HepG2 spheroid generation. Acta Biomater. 2014; 10(5):1965-74. DOI: 10.1016/j.actbio.2013.12.044. View

Wang W, Yuan T, Ma L, Zhu Y, Bao J, Zhao X . Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors. Adv Sci (Weinh). 2022; 9(22):e2105810. PMC: 9353440. DOI: 10.1002/advs.202105810. View

Xu H, Jiao D, Liu A, Wu K . Tumor organoids: applications in cancer modeling and potentials in precision medicine. J Hematol Oncol. 2022; 15(1):58. PMC: 9103066. DOI: 10.1186/s13045-022-01278-4. View

Lam Y, Yu J, Huang H, Ding X, Wong A, Leung H . TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk. Hepatology. 2022; 78(3):727-740. PMC: 10086078. DOI: 10.1002/hep.32802. View

Schneeberger K, Sanchez-Romero N, Ye S, van Steenbeek F, Oosterhoff L, Palacin I . Large-Scale Production of LGR5-Positive Bipotential Human Liver Stem Cells. Hepatology. 2019; 72(1):257-270. PMC: 7496924. DOI: 10.1002/hep.31037. View

Momota H, Shih A, Edgar M, Holland E . c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice. Oncogene. 2008; 27(32):4392-401. DOI: 10.1038/onc.2008.81. View

Driehuis E, Van Hoeck A, Moore K, Kolders S, Francies H, Gulersonmez M . Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc Natl Acad Sci U S A. 2019; 116(52):26580-26590. PMC: 6936689. DOI: 10.1073/pnas.1911273116. View

Kim S, Min S, Choi Y, Jo S, Jung J, Han K . Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids. Nat Commun. 2022; 13(1):1692. PMC: 8967832. DOI: 10.1038/s41467-022-29279-4. View

Jager M, Blokzijl F, Sasselli V, Boymans S, Janssen R, Besselink N . Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat Protoc. 2017; 13(1):59-78. DOI: 10.1038/nprot.2017.111. View

10.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

11.

Demyan L, Habowski A, Plenker D, King D, Standring O, Tsang C . Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy. Ann Surg. 2022; 276(3):450-462. PMC: 10202108. DOI: 10.1097/SLA.0000000000005558. View

12.

Lee S, Hu W, Matulay J, Silva M, Owczarek T, Kim K . Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell. 2018; 173(2):515-528.e17. PMC: 5890941. DOI: 10.1016/j.cell.2018.03.017. View

13.

Lin R, Lin R, Chang H . Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 2008; 3(9-10):1172-84. DOI: 10.1002/biot.200700228. View

14.

Sato T, Vries R, Snippert H, van de Wetering M, Barker N, Stange D . Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262-5. DOI: 10.1038/nature07935. View

15.

Jorgensen A, Young J, Nielsen J, Joensen U, Toft B, Rajpert-De Meyts E . Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche. Br J Cancer. 2014; 110(10):2604-14. PMC: 4021512. DOI: 10.1038/bjc.2014.160. View

16.

Zhang S, Iyer S, Ran H, Dolgalev I, Gu S, Wei W . Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. Cancer Discov. 2020; 11(2):362-383. PMC: 7858239. DOI: 10.1158/2159-8290.CD-20-0455. View

17.

Yoshida G . Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020; 13(1):4. PMC: 6947974. DOI: 10.1186/s13045-019-0829-z. View

18.

Wang H, Zhang C, Peng K, Chen Z, Su J, Li Y . Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study. Cell Rep Med. 2023; 4(2):100911. PMC: 9975107. DOI: 10.1016/j.xcrm.2022.100911. View

19.

Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L . An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun. 2020; 11(1):1310. PMC: 7066173. DOI: 10.1038/s41467-020-15155-6. View

20.

Yi H, Jeong Y, Kim Y, Choi Y, Moon H, Park S . A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat Biomed Eng. 2019; 3(7):509-519. DOI: 10.1038/s41551-019-0363-x. View